Y Takada

Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group.

Satoshi Kudoh, Yasuhiro Fujiwara, Y Takada et al. · Journal of Clinical Oncology · 1998 · 170 citations

Medicine, Oncology, Pharmacology +14

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer

Shunichi Negoro, N Masuda, Y Takada et al. · British Journal of Cancer · 2003 · 153 citations · Full text

Medicine, Oncology, Pharmacology +11

Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients

Masahide Fukudo, Ikuko Yano, Satohiro Masuda et al. · Clinical Pharmacology & Therapeutics · 2005 · 88 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase I–II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer

Yuichiro Ohe, Shunichi Negoro, Kunihiko Matsui et al. · Annals of Oncology · 2005 · 87 citations · Full text

Medicine, Oncology, Pharmacology +11

Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104)

Koji Takeda, Shunichi Negoro, Tomohide Tamura et al. · Annals of Oncology · 2009 · 67 citations

Medicine, Oncology, Pharmacology +12